S&P 500 Futures
(0.08%) 5 331.50 points

Dow Jones Futures
(0.01%) 40 142 points

Nasdaq Futures
(0.13%) 18 659 points

Oil
(-0.06%) $80.01

Gas
(0.53%) $2.64

Gold
(1.12%) $2 444.50

Silver
(2.83%) $32.15

Platinum
(0.33%) $1 093.60

USD/EUR
(-0.02%) $0.920

USD/NOK
(-0.05%) $10.67

USD/GBP
(0.03%) $0.787

USD/RUB
(-0.29%) $90.71

Realtime updates for PT Indofarma Tbk [INAF.JK]

Exchange: JKT Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Last Updated20 May 2024 @ 03:55

25% discount on Stockinvest.us - Use code: Podcast

8.94% IDR 268.00

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 03:55):

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory...

Stats
Today's Volume	103 200
Average Volume	191 937
Market Cap	830.60B
EPS	IDR0 ( 2024-05-15 )
Next earnings date	( IDR0 ) 2024-07-31
Last Dividend	IDR0 ( N/A )
Next Dividend	IDR0 ( N/A )
P/E	-1.900
ATR14	IDR0 (0.00%)

PT Indofarma Tbk Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PT Indofarma Tbk Financials

Annual	2022
Revenue:	IDR1 144.11B
Gross Profit:	IDR-110.11B (-9.62 %)
EPS:	IDR-138.25

FY	2022
Revenue:	IDR1 144.11B
Gross Profit:	IDR-110.11B (-9.62 %)
EPS:	IDR-138.25

FY	2021
Revenue:	IDR2 901.99B
Gross Profit:	IDR451.65B (15.56 %)
EPS:	IDR-13.63

FY	2020
Revenue:	IDR1 715.59B
Gross Profit:	IDR400.60B (23.35 %)
EPS:	IDR0.0100

Financial Reports:

No articles found.

PT Indofarma Tbk Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PT Indofarma Tbk

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.